Analyst firms · Citizens JMP · ZS

Citizens JMP ZS price target and rating history

Zscaler Inc. (ZS) · Technology

Citizens JMP rates Zscaler Inc. (ZS) Mkt Outperform with a $350 price target, as of its latest action on Feb 22, 2022. It has published 4 rating actions on ZS since August 2021, including 0 upgrades and 0 downgrades. Across 12 firms with a ZS price target in the last 12 months, the median target is $215.

Current rating
Mkt Outperform
Price target
$350
Median target, all firms
$215
Actions on ZS
4

Citizens JMP price target on ZS

$400$335$27020222023202420252026
Citizens JMP price target on ZS, each point a stated target, August 2021 to February 2022.

Every Citizens JMP rating on ZS

How other firms rate ZS

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
DA DavidsonNeutral$215Oct 21, 2026
WedbushOutperform$215Sep 11, 2026
BMO Capital MarketsOutperform$200Sep 4, 2026
GuggenheimBuy$214Jun 1, 2026
Evercore ISIIn-line$155May 27, 2026
B. Riley SecuritiesBuy$225May 18, 2026
Morgan StanleyEqual-Weight$155Apr 22, 2026
BTIGNeutralApr 9, 2026
Wells FargoOverweight$200Mar 3, 2026
BernsteinOutperform$228Feb 13, 2026
MizuhoOutperform$310Dec 16, 2025
Capital OneOverweight$320Nov 26, 2025
NeedhamBuy$310Nov 26, 2025

Questions about Citizens JMP and ZS

What is Citizens JMP's price target for ZS?
Citizens JMP's latest stated price target for Zscaler Inc. (ZS) is $350, from its action on Feb 22, 2022.
What is Citizens JMP's rating on ZS?
Citizens JMP rates ZS Mkt Outperform, a bullish rating, as of Feb 22, 2022.
When did Citizens JMP last change its view on ZS?
On Feb 22, 2022, Citizens JMP resumes coverage at Mkt Outperform, price target $400 to $350.
How does Citizens JMP's ZS target compare with other analysts?
Across 12 firms with a ZS price target in the last 12 months, the median target is $215.

More ZS rating histories

All Citizens JMP ratingsZS news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.